Drug · DIN 02479613
AIMOVIG
SINGLE-USE PREFILLED AUTO-INJECTOR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 4, 2018; first marketed December 4, 2018.
- Drug Identification Number (DIN)
- 02479613
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Erenumab N02CD01
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ERENUMAB | 70 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 1, 2018: NOC 21166New Drug Submission (NDS)
Other DINs named AIMOVIG
- DIN 02487306 · Marketed
- DIN 02479605 · Approved
- DIN 02487292 · Approved